Researcher
Chantal Mathieu
- Disciplines:Endocrinology and metabolic diseases
Affiliations
- Clinical and Experimental Endocrinology (Division)
Member
From1 Oct 1999 → Today
Projects
1 - 10 of 75
- Continuous glucose monitoring for women with gestational diabetes: a randomized controlled trial: the CORDELIA studyFrom1 Jan 2024 → 29 Mar 2024Funding: Own budget, for example: patrimony, inscription fees, gifts
- European action for the Diagnosis of Early Non-clinical Type 1 diabetes For disease InterceptionFrom1 Nov 2023 → TodayFunding: Horizon Europe - Digital, Industry and Space
- Quality of diabetes care: the role of health dataFrom29 Mar 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Neutrophils: neglected as potential players in autoimmune type 1 diabetes initiation, progression, and perpetuationFrom1 Jan 2023 → TodayFunding: FWO research project (including WEAVE projects)
- Unique IsoPlexis technology for multiplexed single cell functional profilingFrom1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Innovative strategies for screening, diagnosis and prevention of type 1 diabetes.From13 Dec 2022 → 15 Dec 2022Funding: BOF - various
- "SyneRegIm": exploring the SYNErgistic effect of β-cell REGeneration and emerging IMmune intervention strategies to prevent and/or reverse type 1 diabetesFrom1 Sep 2022 → TodayFunding: Foreign private sponsor - undefined
- The SERENA study: Semaglutide for the treatment of glucose intolerance in women with prior gestational diabetes: a double blind RCTFrom30 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization of the dynamic immunophenotype during type 1 diabetes progression to identify predictive biomarkers of anti-CD3 mono- and combination therapy in disease prevention and reversal in miceFrom7 Aug 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
Publications
581 - 590 of 713
- Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres(2011)
Authors: P Pozzilli, NC Schloot, N Hosszufalusi, A Lauria, J Ludvigsson, Chantal Mathieu, D Mauricio, E Rubinat, M Nordwall, Bart Van Der Schueren, et al.
Pages: S74 - S74 - Degludec- First of a new generation of insulins(2011)
Authors: Chantal Mathieu
Pages: 84 - 87 - Vitamin D and diabetes(2011)
Authors: Conny Gysemans, Hannelie Korf, Chantal Mathieu
Pages: 1825 - 1842 - Air pollution-induced procoagulant changes are triggered by circulating microvesicles(2011)
Authors: Jan Emmerechts, L Jacobs, S Van Kerckhoven, Serena Loyen, Chantal Mathieu, F Fierens, Benoit Nemery, Tim Nawrot, Marc Hoylaerts
Pages: 157 - 158 - Ook getest op... diabetes!?(2011)
Authors: Katrien Fouzia Benhalima, Chantal Mathieu
Pages: 32 - 34 - De nieuwe IADPSG-aanbevelingen voor screening en diagnose van zwangerschapsdiabetes: hoe implementeren?(2011)
Authors: Katrien Fouzia Benhalima, Roland Devlieger, Johan Verhaeghe, Chantal Mathieu
Pages: 851 - 7 - Vitamin d deficiency and chronic obstructive pulmonary disease a vicious circle(2011)
Authors: Wim Janssens, Chantal Mathieu, Steven Boonen, Marc Decramer
Pages: 379 - 99 - Traffic Air Pollution and Oxidized LDL(2011)
Authors: Lotte Jacobs, Jan Emmerechts, Marc Hoylaerts, Chantal Mathieu, Peter Hoet, Benoit Nemery de Bellevaux, Tim Nawrot
- Patients' experiences with patient-centered care are associated with documented outcome of care indicators for diabetes: findings from the Leuven Diabetes Project(2011)
Authors: Geert Goderis, Geert Verbeke, An Carbonez, Anna Ivanova, Chantal Mathieu, Jan Heyrman
Pages: 65 - 75 - High glucose induces dysfunction in insulin secretory cells by different pathways: a proteomic approach(2010)
Authors: Michael Maris, Wannes D'Hertog, Etienne Waelkens, Lut Overbergh, Chantal Mathieu
Pages: 6274 - 6287
Patents
1 - 6 of 6
- Biomarkers for diabetes therapy (Inventor)
- Biomarkers for diabetes therapy (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- Citrullinated peptides for diagnosis or treatment of diabetes (Inventor)
- Improved methods for pancreatic islet transplantation (Inventor)
- RESISTANCE TO OXIDATIVE STRESS (Inventor)